A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

Scientists from the Krembil Brain Institute and the University of Toronto have made an exciting discovery that could open new ...

An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...

GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 18, 2024 - AB ...

Doctors hail breakthrough in fight against Parkinson'sIn multiple pockets across the country, scientists are watching a ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Coya’s investigational product candidate pipeline leverages multiple therapeutic ... of action that is now being developed for the treatment of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, ...

Setbacks in Parkinson’s Drugs Highlight Need for Novel Therapies This month has seen the failure of main assets in the ...

ABOVE: Protein misfolding plays an important role in many neurodegenerative disorders. © istock.com, Eoneren. W hen Julie ...

Supernus Pharmaceuticals saw strong stock performance, has a diverse drug portfolio, and potential for significant future ...